U-Ploid Biotechnologies Ltd
15432020
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 25/09/2024
BIOTECHNOLOGY
AUSTRALIAN,AMERICAN · UNITED STATES · Age 48
Persons with Significant Control
Dr Alexandre Webster
British,American · United Kingdom · Age 40
Building 696, Innovation Building, Bioescalator, Old Road Campus, Roosevelt Drive, Oxford, OX3 7FZ
Notified 22/01/2024
Dr Chloe Amelia Charalambous
British · England · Age 31
Building 696, Innovation Building, Bioescalator, Old Road Campus, Roosevelt Drive, Oxford, OX3 7FZ
Notified 23/07/2024
CompanyRankvs 481+ SIC 72110 peers73
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/01/2026
Net Worth
£716k
Balance sheet strength
Cash
£585k
Cash in the bank
Net Current Assets
£600k
Working capital
Current Assets
£618k
Current Liabilities
£18k
Fixed Assets
£116k
Debtors
£33k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2026 | 34.32 |
| 2025 | 28.56 |
Derived from filed accounts. Not audited figures.